You have 9 free searches left this month | for more free features.

ATTR

Showing 1 - 25 of 135

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ATTR Cardiac Amyloidosis in Patients Undergoing TAVR

Not yet recruiting
  • ATTR Amyloidosis Wild Type
  • +3 more
    • (no location specified)
    Aug 23, 2023

    Mitral Regurgitation, ATTR-Cardiomyopathy, Edge-to-Edge Mitral Valve Repair Trial (TEER, Optimal Medical Therapy)

    Not yet recruiting
    • Mitral Regurgitation
    • +2 more
    • TEER
    • Optimal Medical Therapy
    • (no location specified)
    Oct 4, 2023

    Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Trial (NTLA-2001, Placebo)

    Not yet recruiting
    • Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
    • NTLA-2001
    • Placebo
    • (no location specified)
    Nov 8, 2023

    Amyloidosis, Hereditary Trial in Richmond (Registry)

    Not yet recruiting
    • Amyloidosis, Hereditary
    • Registry
    • Richmond, Virginia
      Virginia Commonwealth University
    Jul 25, 2023

    Learn About Tafamidis in Transthyretin Amyloid Cardiomyopathy in

    Not yet recruiting
    • Transthyretin Amyloid Cardiomyopathy
    • (no location specified)
    Oct 11, 2023

    Transthyretin Amyloidosis Trial in New Haven (Computer algorithm for ATTR)

    Not yet recruiting
    • Transthyretin Amyloidosis
    • Computer algorithm for ATTR
    • New Haven, Connecticut
      Yale New Haven Hospital
    Jan 20, 2023

    Transthyroxine Amyloidosis Cardiomyopathy Trial in Hangzhou (ATTR-CM)

    Recruiting
    • Transthyroxine Amyloidosis Cardiomyopathy
    • Hangzhou, Zhejiang, China
      xiaohong University PAN
    Jan 29, 2023

    Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Trial in Indianapolis (Eplontersen)

    Recruiting
    • Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
    • Indianapolis, Indiana
      Indiana University Health University Hospital
    Jan 12, 2023

    Amyloidosis Cardiac, Virtual Reality Trial in Düsseldorf (Intervention)

    Not yet recruiting
    • Amyloidosis Cardiac
    • Virtual Reality
    • Intervention
    • Düsseldorf, NRW, Germany
      University-Hospital Düsseldorf Division of Cardiology, Pulmonary
    Jul 3, 2023

    Aortic Stenosis Symptomatic, Amyloidosis Cardiac Trial in Bern (Tc-99m-DPD scintigraphy)

    Active, not recruiting
    • Aortic Stenosis Symptomatic
    • Amyloidosis Cardiac
    • Tc-99m-DPD scintigraphy
    • Bern, BE, Switzerland
      University Hospital Bern - Inselspital
    Dec 14, 2022

    Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,

    Recruiting
    • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
    • +2 more
    • NTLA-2001
    • Paris, France
    • +3 more
    Nov 29, 2022

    Transthyretin-mediated Amyloidosis With Cardiomyopathy, ATTR Amyloidosis With Cardiomyopathy Trial (Patisiran)

    Available
    • Transthyretin-mediated Amyloidosis With Cardiomyopathy
    • ATTR Amyloidosis With Cardiomyopathy
    • (no location specified)
    Aug 17, 2022

    Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,

    Recruiting
    • Systemic Amyloidosis
    • 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
    • 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
    • Knoxville, Tennessee
      University of Tennessee Graduate School of Medicine
    Jul 10, 2023

    Cardiomyopathies, Primary Trial ((18F)Flutemetamol)

    Recruiting
    • Cardiomyopathies, Primary
    • New Haven, Connecticut
      Yale University
    Oct 11, 2022

    Quantitative-imaging in Cardiac Transthyretin Amyloidosis

    Recruiting
    • ATTR-CM
    • 18F-fluoride PET
    • Groningen, Netherlands
      University Medical Centre Groningen
    Mar 16, 2023

    Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

    Not yet recruiting
    • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
    • +2 more
      • Auckland, New Zealand
      • +2 more
      Jan 24, 2023

      Transthyretin Amyloid Cardiomyopathy Trial in New York (Empagliflozin)

      Recruiting
      • Transthyretin Amyloid Cardiomyopathy
      • New York, New York
        Columbia University Irving Medical Center / NewYork-Presbyterian
      Mar 15, 2022

      Lumbar Spine Stenosis Specimens for Identification of

      Not yet recruiting
      • Lumbar Spinal Stenosis
      • +5 more
      • Tc99-PYP or Tc99-HDMP Scan
      • Beverly Hills, California
      • +5 more
      Sep 12, 2023

      Vyndamax® Capsules for Treatment of Transthyretin Amyloid

      Recruiting
      • ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
      • Vyndamax (tafamidis 61mg)
      • Seoul, Korea, Republic of
        Pfizer
      Aug 16, 2022

      Study of Transthyretin-Mediated Amyloidosis

      Recruiting
      • Transthyretin-Mediated Amyloidosis
      • ATTR Amyloidosis
        • La Jolla, California
        • +23 more
        Jan 13, 2023

        ATTR Amyloidosis Trial in Pavia

        Recruiting
        • ATTR Amyloidosis
          • Pavia, Italy
            Fondazione IRCCS Policlinico San Matteo
          Jul 13, 2022

          Symptomatic Transthyretin Amyloid Cardiomyopathy Trial in Japan (ALXN2060)

          Active, not recruiting
          • Symptomatic Transthyretin Amyloid Cardiomyopathy
          • Aichi, Japan
          • +12 more
          Dec 12, 2022

          Cardiac Amyloidosis Trial in London (Telemonitoring service)

          Not yet recruiting
          • Cardiac Amyloidosis
          • Telemonitoring service
          • London, United Kingdom
            Richmond Research Institute
          Jan 18, 2022

          Transthyretin Amyloid Cardiomyopathy (ATTR CM) Trial in Baltimore (NNC6019-0001, Placebo (NNC6019-0001))

          Recruiting
          • Transthyretin Amyloid Cardiomyopathy (ATTR CM)
          • Baltimore, Maryland
            Novo Nordisk Investigational Site
          Aug 9, 2022

          Vyndaqel Capsules Special Investigation (ATTR-CM)

          Recruiting
          • Transthyretin (TTR) Amyloid Cardiomyopathy
          • Treatment for TTR amyloidosis
          • Tokyo, Japan
            Pfizer
          Jun 15, 2022